This video is featured in the 2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: HRQoL With Luspatercept vs. Epoetin Alfa in RBC Transfusion-Dependent Lower-Risk MDS - COMMANDS Study
By
2024 ASH Annual Meeting Insights Hub
FEATURING
Esther Oliva
By
2024 ASH Annual Meeting Insights Hub
FEATURING
Esther Oliva
26 views
December 20, 2024
Comments 0
Login to view comments.
Click here to Login